α2,3 and α2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6
Top Cited Papers
Open Access
- 15 September 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (18) , 9093-9103
- https://doi.org/10.1128/jvi.00895-06
Abstract
Recombinant adeno-associated viruses (AAVs) are promising vectors in the field of gene therapy. Different AAV serotypes display distinct tissue tropism, believed to be related to the distribution of their receptors on target cells. Of the 11 well-characterized AAV serotypes, heparan sulfate proteoglycan and sialic acid have been suggested to be the attachment receptors for AAV type 2 and types 4 and 5, respectively. In this report, we identify the receptor for the two closely related serotypes, AAV1 and AAV6. First, we demonstrate using coinfection experiments and luciferase reporter analysis that AAV1 and AAV6 compete for similar receptors. Unlike heparin sulfate, enzymatic or genetic removal of sialic acid markedly reduced AAV1 and AAV6 binding and transduction. Further analysis using lectin staining and lectin competition assays identified that AAV1 and AAV6 use either α2,3-linked or α2,6-linked sialic acid when transducing numerous cell types (HepG2, Pro-5, and Cos-7). Treatment of cells with proteinase K but not glycolipid inhibitor reduced AAV1 and AAV6 infection, supporting the hypothesis that the sialic acid that facilitates infection is associated with glycoproteins rather than glycolipids. In addition, we determined by inhibitor (N-benzyl GalNAc)- and cell line-specific (Lec-1) studies that AAV1 and AAV6 require N-linked and not O-linked sialic acid. Furthermore, a resialylation experiment on a deficient Lec-2 cell line confirmed a 2,3 and 2,6 N-linked sialic acid requirement, while studies of mucin with O-linked sialic acid showed no inhibition effect for AAV1 and AAV6 transduction on Cos-7 cells. Finally, using a glycan array binding assay we determined that AAV1 efficiently binds to NeuAcα2-3GalNAcβ1-4GlcNAc, as well as two glycoproteins with α2,3 and α2,6 N-linked sialic acids. Taken together, competition, genetic, inhibitor, enzymatic reconstitution, and glycan array experiments support α2,3 and α2,6 sialic acids that are present on N-linked glycoproteins as primary receptors for efficient AAV1 and AAV6 viral infection.Keywords
This publication has 59 references indexed in Scilit:
- Gangliosides Are Essential for Bovine Adeno-Associated Virus EntryJournal of Virology, 2006
- Identification and Characterization of Novel Adeno-Associated Virus Isolates in ATCC Virus StocksJournal of Virology, 2006
- Enterovirus 70 Binds to Different Glycoconjugates Containing α2,3-Linked Sialic Acid on Different Cell LinesJournal of Virology, 2005
- Intracellular trafficking of adeno-associated viral vectorsGene Therapy, 2005
- Efficient Transduction of Vascular Endothelial Cells with Recombinant Adeno-Associated Virus Serotype 1 and 5 VectorsHuman Gene Therapy, 2005
- Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapyBlood, 2003
- Secreted and Transmembrane Mucins Inhibit Gene Transfer with AAV4 More Efficiently than AAV5Journal of Biological Chemistry, 2002
- Development of a Pharmaceutical Apotransferrin Product for Iron Binding TherapyBiologicals, 2001
- Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment onTetrahymena pyriformis: data on the evolution of the signaling systemCell Biochemistry and Function, 2000
- Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrinFEBS Letters, 1975